Trial intelligence / Profile preview

Oxybutynin lotion for palmar dyshidrosis pruritus (intra-individual exploratory study)

jRCTs051240187Recruiting

Start
Nov 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of oxybutynin in dyshidrosis (2 arms). Primary endpoint: Change in pruritus Numeric Rating Scale (NRS) from baseline to Week 4. Started Nov 2024; status: recruiting.

02

Drugs

oxybutynin
03

Conditions

dyshidrosis

Beyond the preview

Go deeper on jRCTs051240187.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs051240187.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call